Search Result "dolutegravir"
The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor
Journal: Current Clinical Pharmacology
Volume: 11 Issue: 2 Year: 2016 Page: 88-94
Author(s): Harmanjit Singh,Mandeep Kaur,Ashish K. Kakkar,Harish Kumar
Novel Second Generation HIV Integrase Inhibitor-DOLUTEGRAVIR: An Emerging Weapon Against HIV
Journal: Letters in Drug Design & Discovery
Volume: 14 Issue: 3 Year: 2017 Page: 354-371
Author(s): Vivek Jain,Diksha Gupta,Ashutosh Pareek,Yashumati Ratan
Dolutegravir-Related Neurological Adverse Events: A Case Report of Successful Management with Therapeutic Drug Monitoring
Journal: Current Drug Safety
Volume: 13 Issue: 1 Year: 2018 Page: 69-71
Author(s): Francois Parant,Patrick Miailhes,Florence Brunel,Marie-Claude Gagnieu
A Novel Integrase Targeting Agent to Explore the Future Prospective of HIV Eradication: Dolutegravir
Journal: Current HIV Research
Volume: 12 Issue: 5 Year: 2014 Page: 325-338
Author(s): Bawneet K. Narang,Gurpreet K. Grewal,Subhajit Roy,Jitender Bariwal,Manish K. Gupta,Ravindra K. Rawal
Dolutegravir Plus Lamivudine as Initial Therapy for HIV-1 Infected andARV-naïve Patients in West China, 24-Weeks Results of a PreliminaryReal-world Study
Journal: Current HIV Research
Volume: 20 Issue: 3 Year: 2022 Page: 222-227
Author(s):
An Improved Preparation of (R)-3-Aminobutanol, a Key Intermediate for the Synthesis of Dolutegravir Sodium
Journal: Letters in Drug Design & Discovery
Volume: 14 Issue: 1 Year: 2017 Page: 1371-1375
Author(s): Y. Srinivasa Rao, B. Hari Babu, I. Aminual, D. Nageshwar , P.V.V. Satyanarayana
Anti-HIV Integrase Inhibitors as New Candidates for the Treatment ofCOVID-19: A Narrative Literature Review
Journal: Anti-Infective Agents
Volume: 20 Issue: 2 Year: 2022 Page: 59-64
Author(s): Sofia Salari,Hedyieh Karbasforooshan,Hesamoddin Hosseinjani
Integrase Inhibitors
Ebook: Frontiers in HIV Research
Volume: 1 Year: 2015
Author(s): Sarah Nanzigu,Francis Xavier Kasujja
Doi: 10.2174/9781681080567115010008
Integrase Strand Transfer Inhibitor (INSTI) Genotypic Resistance Analysisin Treatment-Naive, INSTI Free Antiretroviral-Experienced andINSTI-Experienced Turkish Patients Infected with HIV-1
Journal: Current HIV Research
Volume: 20 Issue: 2 Year: 2022 Page: 184-192
Author(s): Figen Sarigul Yildirim
Recent Advances in Antiretroviral Agents: Potent Integrase Inhibitors
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 18 Year: 2017 Page: 2552-2567
Author(s): Mina Psichogiou,Garyphalia Poulakou,Dimitrios Basoulis,Dimitrios Paraskevis,Antonios Markogiannakis,George L. Daikos